Amy S. Paller
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
2020/01/30 by E.L. Simpson, Eric L. Simpson, J.‐P. Lacour +43 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
2020/06/01 by Alan Menter, Joel M. Gelfand, Cody Connor +31 · 1 citation
- Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
2025/05/12 by Masahiro Kamata, Dingyuan I. Sun, Amy S. Paller · 1 voice · 1 citation
Medicine · Health Professions · #Dermatology and Skin Diseases #Health and Medical Studies
- Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )
2020/04/21 by A.S. Paller, Amy S. Paller, M.M.B. Seyger +27 · 25 citations
Immunology and Microbiology · Medicine · #Psoriasis: Treatment and Pathogenesis #Spondyloarthritis Studies and Treatments #Dermatology and Skin Diseases
- Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label <scp>CADMUS</scp> Jr study
2020/03/16 by Sandra Philipp, S. Philipp, Alan Menter +20 · 25 citations
Immunology and Microbiology · Medicine · #Psoriasis: Treatment and Pathogenesis #Spondyloarthritis Studies and Treatments #Autoimmune and Inflammatory Disorders Research